Studies have demonstrated that CAP1 is overexpressed in hepatocelluar carcinoma (24), breast cancer (25), lung cancer (26) and esophageal squamous cell carcinoma (27). This evidence concerns the gene CAP1 and esophageal squamous cell carcinoma.